Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE)
ASX:ONE
Want to see AU:ONE full AI Analyst Report?
ONE Stock Chart & Stats
AU$0.26
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.26
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.16 - AU$0.41
Previous CloseN/A
Volume4.96K
Average Volume (3M)344.03K
Market Cap
AU$122.76M
Enterprise ValueAU$94.86M
Total Cash (Recent Filing)AU$4.60M
Total Debt (Recent Filing)AU$1.99M
Price to Earnings (P/E)―
Beta1.38
Next Earnings
Sep 01, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding838,984,740
10 Day Avg. Volume303,620
30 Day Avg. Volume344,030
Financial Highlights & Ratios
PEG Ratio0.76
Price to Book (P/B)47.09
Price to Sales (P/S)14.39
P/FCF Ratio-20.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.45Price Target Upside73.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.01
Revenue Forecast (FY)AU$14.95M
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Deployment MomentumSustained double‑digit revenue growth (21% in 2025) combined with a 31% acceleration in H2 deployments and a management target to grow endpoints ~20% to ~18,000 indicate improving product‑market fit and scalable recurring revenue potential, supporting durable top‑line expansion if conversion continues.
Baxter Partnership And GPO AccessInclusion in a major Baxter‑linked GPO and a 156+ qualified‑opportunity Baxter pipeline materially expands addressable market and reduces commercial friction with large U.S. health systems, enabling structurally greater access to enterprise deals and improving long‑term sales scalability.
Product, AI Innovation And Cost EfficiencyNew AI‑driven product suite (Ovie ecosystem), measurable SDLC productivity gains (engineer time savings up to 76% reporting >15% daily savings) and carried‑forward OpEx cuts (>€1.4m annualized) create durable advantages: faster feature delivery, lower unit costs and improved operating leverage as scale grows.
Bears Say
Ongoing Operating Losses And Cash BurnThe company remains loss‑making with a €8.1m operating EBITDA loss and only €4.6m cash at year‑end, while operating and free cash flows are consistently negative. This persistent cash burn increases reliance on external funding and risks execution if deal conversion slows.
Long Sales Cycles And Pipeline Conversion RiskLengthy enterprise sales (18–24 months) and dependence on large pipeline conversions (eg. Baxter/GPO) mean revenue realization is timing‑uncertain. This structural sales cadence amplifies execution risk and can delay scaled revenue or cash generation despite a healthy pipeline.
Margin Pressure And Customer/regulatory HeadwindsGross margin compression from higher non‑recurring, lower‑margin mix and isolated customer decommissions highlight vulnerability to client budget pressure. Added U.S. regulatory and capital‑spending uncertainty could further disrupt deployment timing and margin stability over the medium term.
Oneview Healthcare Chess Depository Interests repr 1 News
ONE FAQ
What was Oneview Healthcare PLC Chess Depository Interests repr 1’s price range in the past 12 months?
Oneview Healthcare PLC Chess Depository Interests repr 1 lowest share price was AU$0.15 and its highest was AU$0.41 in the past 12 months.
What is Oneview Healthcare PLC Chess Depository Interests repr 1’s market cap?
Oneview Healthcare PLC Chess Depository Interests repr 1’s market cap is AU$122.76M.
When is Oneview Healthcare PLC Chess Depository Interests repr 1’s upcoming earnings report date?
Oneview Healthcare PLC Chess Depository Interests repr 1’s upcoming earnings report date is Sep 01, 2026 which is in 103 days.
How were Oneview Healthcare PLC Chess Depository Interests repr 1’s earnings last quarter?
Oneview Healthcare PLC Chess Depository Interests repr 1 released its earnings results on Feb 11, 2026. The company reported -AU$0.01 earnings per share for the quarter, beating the consensus estimate of -AU$0.012 by AU$0.002.
Is Oneview Healthcare PLC Chess Depository Interests repr 1 overvalued?
According to Wall Street analysts Oneview Healthcare PLC Chess Depository Interests repr 1’s price is currently Undervalued.
Does Oneview Healthcare PLC Chess Depository Interests repr 1 pay dividends?
Oneview Healthcare PLC Chess Depository Interests repr 1 does not currently pay dividends.
What is Oneview Healthcare PLC Chess Depository Interests repr 1’s EPS estimate?
Oneview Healthcare PLC Chess Depository Interests repr 1’s EPS estimate is >-0.01.
How many shares outstanding does Oneview Healthcare PLC Chess Depository Interests repr 1 have?
Oneview Healthcare PLC Chess Depository Interests repr 1 has 838,984,740 shares outstanding.
What happened to Oneview Healthcare PLC Chess Depository Interests repr 1’s price movement after its last earnings report?
Oneview Healthcare PLC Chess Depository Interests repr 1 reported an EPS of -AU$0.01 in its last earnings report, beating expectations of -AU$0.012. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of Oneview Healthcare PLC Chess Depository Interests repr 1?
Currently, no hedge funds are holding shares in AU:ONE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oneview Healthcare Chess Depository Interests repr 1 Stock Smart Score
Company Description
Oneview Healthcare PLC Chess Depository Interests repr 1
Oneview Healthcare Chess Depository Interests repr 1 (ONE) is a healthcare technology company that focuses on providing innovative digital solutions to enhance patient and operational outcomes in the healthcare sector. The company primarily offers a digital patient engagement platform that streamlines communication between healthcare providers and patients, facilitates data sharing, and improves overall patient experience. Oneview Healthcare operates within the broader healthcare technology industry, catering to hospitals, clinics, and other healthcare organizations seeking to modernize their patient care processes.
Oneview Healthcare Chess Depository Interests repr 1 (ONE) Earnings & Revenues
ONE Company Deck
ONE Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicates strong commercial momentum and meaningful progress on product innovation and AI‑driven productivity—highlighted by 21% reported revenue growth (25%+ constant currency), accelerated deployments, a major Baxter partnership and clear cost‑efficiency gains (H2 OpEx down and >EUR 1.4m annualized run‑rate savings). However, material challenges remain: the company is still operating at an EBITDA loss (EUR 8.1m), cash is modest (EUR 4.6m), gross margin was compressed by revenue mix and conversion of a large Baxter/GPO pipeline and enterprise expansions are uncertain and subject to lengthy sales cycles and regulatory/capital‑spending risks. On balance, the positives (growth, partnerships, product/AI progress and OpEx improvement) outweigh the negatives, but execution and pipeline conversion will be critical to sustain the trajectory.View all AU:ONE earnings summariesONE Stock 12 Month Forecast
Average Price Target
AU$0.45
▲(73.08% Upside)
Technical Analysis
Mach7 Technologies
―
Beamtree Holdings Ltd
―
MedAdvisor Limited
―
Alcidion Group Limited
―
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh
―
Options Prices
Currently, No data available
---